If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Market Research, Analytics and Forecasting » Analytics
Download FREE Excerpt
11 Info Graphics
64 Data Graphics
12 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
However, the inherent costs, uneven senior management buy-in, difficulty in measuring ROI of Big Data and other challenges that come with harnessing large sets of information in varied formats have caused the pharmaceutical sector to embrace Big Data analytics slower than other industries.
As the pharmaceutical industry strives to develop big data capabilities, they are wrestling with questions such as:
Best Practices, LLC engaged 22 leaders from 18 pharmaceutical companies through a benchmarking survey.
Research analysts also conducted seven deep-dive executive interviews with selected benchmark participants
Most Have Centralized or Dedicated Big Data Team or Function: Half of the study participants for both the medical and HEOR segments said they have a centralized/dedicated group (Big Data team or function) to support Big Data projects. For the commercial segment, 40% said they have a centralized/dedicated Big Data group.
Majority of Each Segment Rate Internal Groups as Most Impactful Targets for Data Analysis: Internal Commercial, Medical and Development functions were rated by a majority of medical, commercial and HEOR respondents as the most impactful targets for data analysis presentations. A majority of each segment also said these internal groups were also the most frequent requestors of presentations.
Table of Contents